$2,303.65 travel Payment -- Teva Pharmaceuticals to Dr. Charles Baker

Teva Pharmaceuticals covers $2,303.65 in travel and lodging for Internal Medicine physician Dr. Charles Baker.

This page provides a detailed analysis of a $2,303.65 travel payment from Teva Pharmaceuticals to Dr. Charles Baker. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$2,303.65
Payment Typetravel
Payment NatureTravel and Lodging
Pharmaceutical CompanyTeva Pharmaceuticals
PhysicianDr. Charles Baker
NPI Number1283275824
Physician SpecialtyInternal Medicine
LocationGreensboro, NC
Date of Payment2025-05-31
Conflict AssessmentLow -- Routine

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Teva Pharmaceuticals made a $2.3K travel payment to Charles Baker, a Internal Medicine specialist in Greensboro, NC. Teva Pharmaceuticals paid $2,303.65 for travel and lodging to Dr. Charles Baker, an Internal Medicine physician. The payment occurred on May 31, 2025, and was associated with the payment ID OP-MNHLXOXH-KTYEXZ. Dr. Baker is located in Greensboro, NC, and his NPI is 1283275824.

Patient Guidance: What This Payment Means for You

This payment covers travel and lodging expenses for a physician, which may be related to educational events or professional development. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Payments for travel and lodging are common in the pharmaceutical industry, particularly for physicians attending educational conferences or engaging in research collaborations.

Regulatory Context: Sunshine Act Requirements

This payment is subject to reporting requirements under the Physician Payments Sunshine Act, which mandates disclosure of payments made by manufacturers of drugs, devices, and biologics to physicians and teaching hospitals.

Related Topics

This payment is related to the following healthcare transparency topics:

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $2.3K payment for?

This was a travel payment of $2.3K from Teva Pharmaceuticals to Charles Baker, categorized as "Travel and Lodging". The payment was reported under the Sunshine Act (CMS Open Payments).

Does Charles Baker accept pharmaceutical money?

Yes, Charles Baker received this $2.3K payment from Teva Pharmaceuticals. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Charles Baker's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $2.3K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Internal Medicine?

To compare this payment against Internal Medicine averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Internal Medicine physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Charles Baker's relationship with Teva Pharmaceuticals?

The payment was specifically for 'Travel and Lodging'. This $2.3K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Internal Medicine?

The payment date is in the future (May 31, 2025).

What should patients do after learning about this payment?

This payment covers travel and lodging expenses for a physician, which may be related to educational events or professional development.

What else should I know about this travel payment?

The payment was made by Teva Pharmaceuticals.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.